{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:28Z","timestamp":1790710948541,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01248","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:46:10Z","timestamp":1590626770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?"],"prefix":"10.3389","volume":"11","author":[{"given":"Athar","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Nemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102434","DOI":"10.1016\/j.jaut.2020.102434","article-title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in china","volume":"109","author":"Yang","year":"2020","journal-title":"J Autoimmun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E372","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses."},{"key":"B3","doi-asserted-by":"publisher","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin Immunol."},{"key":"B4","unstructured":"WHOCoronavirus Disease 20192020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.20944\/preprints202002.0220.v1","article-title":"Pulmonary pathology of early phase SARS-COV-2 pneumonia","volume":"15","author":"Tian","year":"2020","journal-title":"J. Thoracic Oncology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","article-title":"COVID-19: melatonin as a potential adjuvant treatment","volume":"250","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.7150\/ijbs.45134","article-title":"COVID-19: what has been learned and to be learned about the novel coronavirus disease","volume":"16","author":"Yi","year":"2020","journal-title":"Int J Biol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1378\/chest.107.4.1062","article-title":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1\u03b2 and IL-6 levels are consistent and efficient predictors of outcome over time","volume":"107","author":"Meduri","year":"1995","journal-title":"Chest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S0140-6736(20)30558-4","article-title":"Comorbidities and multi-organ injuries in the treatment of COVID-19","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","article-title":"The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome","volume":"26","author":"Wang","year":"2008","journal-title":"Am J Emerg Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Review: cytokine storm syndrome: looking toward the precision medicine era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3389\/fimmu.2018.01511","article-title":"Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome","volume":"9","author":"Hawkins","year":"2018","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"100016","DOI":"10.1016\/j.xcrm.2020.100016","article-title":"Adjunct immunotherapies for the management of severely ill COVID-19 patients","volume":"22","author":"Bonam","year":"2020","journal-title":"Cell Rep Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21666","article-title":"COVID-19 treatment by repurposing drugs until the vaccine is in sight","author":"Phadke","year":"2020","journal-title":"Drug Dev Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: faraway, so close!","volume":"19","author":"Favalli","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-NCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1055\/a-0873-3529","article-title":"A cautious note on thalidomide usage in cancer treatment: genetic profiling of the Tbx2 sub-family gene expression is required","volume":"69","author":"Nemer","year":"2019","journal-title":"Drug Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41598-017-01641-3","article-title":"A hand to TBX5 explains the link between thalidomide and cardiac diseases","volume":"7","author":"Khalil","year":"2017","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","article-title":"Thalidomide: a review of approved and investigational uses","volume":"25","author":"Matthews","year":"2003","journal-title":"Clin Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00018-010-0619-9","article-title":"Teratogenic effects of thalidomide: molecular mechanisms","volume":"68","author":"Ito","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08830180801911339","article-title":"Thalidomide: mechanisms of action","volume":"27","author":"Paravar","year":"2008","journal-title":"Int Rev Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.det.2010.03.003","article-title":"Innovative uses of thalidomide","volume":"25","author":"Chen","year":"2010","journal-title":"Dermatol Clin."},{"key":"B28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.7150\/ijbs.9224","article-title":"Recent advances in drug repositioning for the discovery of new anticancer drugs","volume":"10","author":"Shim","year":"2014","journal-title":"Int J Biol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e26494","DOI":"10.4161\/onci.26494","article-title":"Trial watch: lenalidomide-based immunochemotherapy","volume":"2","author":"Semeraro","year":"2013","journal-title":"Oncoimmunology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide-induced teratogenesis: history and mechanisms","volume":"105","author":"Vargesson","year":"2015","journal-title":"Birth Defects Res Part C Embryo Today Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0006-2952(99)00388-3","article-title":"Mechanism of action in thalidomide teratogenesis","volume":"59","author":"Stephens","year":"2000","journal-title":"Biochem Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molmed.2017.02.006","article-title":"A brighter side to thalidomide: its potential use in immunological disorders","volume":"23","author":"Millrine","year":"2017","journal-title":"Trends Mol Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejphar.2008.07.019","article-title":"Anti-inflammatory effect of thalidomide alone or in combination with augmentin in Klebsiella pneumoniae B5055 induced acute lung infection in BALB\/c mice","volume":"592","author":"Kumar","year":"2008","journal-title":"Eur J Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2174\/156802612801784443","article-title":"TNF \u03b1 signaling beholds thalidomide saga: a review of mechanistic role of TNF-\u03b1 signaling under thalidomide","volume":"12","author":"Majumder","year":"2012","journal-title":"Curr Top Medi Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-3083.1981.tb00169.x","article-title":"Inhibition of de Novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy","volume":"13","author":"Shannon","year":"1981","journal-title":"Scand J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","article-title":"The immunosuppressive drug thalidomide induces t helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures","volume":"99","author":"Mchugh","year":"2008","journal-title":"Clin Exp Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1128\/AAC.44.9.2286-2290.2000","article-title":"A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma Interferon in healthy humans","volume":"44","author":"Verbon","year":"2000","journal-title":"Antimicrobial Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.intimp.2013.06.005","article-title":"Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in mice","volume":"17","author":"Amirshahrokhi","year":"2013","journal-title":"Int Immunopharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s10753-017-0625-2","article-title":"Antiinflammation and antioxidant effects of thalidomide on pulmonary fibrosis in mice and human lung fibroblasts","volume":"40","author":"Dong","year":"2017","journal-title":"Inflammation."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10753-014-9943-9","article-title":"Anti-inflammatory effect of thalidomide on H1N1 influenza virus-induced pulmonary injury in mice","volume":"37","author":"Zhu","year":"2014","journal-title":"Inflammation."},{"key":"B41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.7326\/0003-4819-157-6-201209180-00003","article-title":"Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial","volume":"157","author":"Horton","year":"2012","journal-title":"Ann Intern Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"3","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B43","unstructured":"Thalidomide combined with low-dose glucocorticoid in the treatment of COVID-19 pneumonia\n            ChenC\n            QiF\n            ShiK\n            LiY\n            LiJ\n            ChenY\n          Preprints2020"},{"key":"B44","unstructured":"XiaJ\n          Clinical TrialsThe Efficacy and Safety of Thalidomide Combined With Low-Dose Hormones in the Treatment of Severe COVID-19.2020"},{"key":"B45","unstructured":"XiaJ\n          The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia - Tabular View.2020"},{"key":"B46","unstructured":"Thalidomide | Recruiting Studies - List Results - ClinicalTrials.Gov2020"},{"key":"B47","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.chest.2018.06.038","article-title":"Treatment of interstitial lung disease associated cough: CHEST guideline and expert panel report","volume":"154","author":"Birring","year":"2018","journal-title":"Chest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fonc.2018.00482","article-title":"Transcriptomic alterations in lung adenocarcinoma unveil new mechanisms targeted by the Tbx2 subfamily of tumor suppressor genes","volume":"8","author":"Khalil","year":"2018","journal-title":"Front Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"68230","DOI":"10.18632\/oncotarget.19938","article-title":"TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection","volume":"8","author":"Khalil","year":"2017","journal-title":"Oncotarget."},{"key":"B50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"B51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2484\/rcr.v2i2.71","article-title":"Acute pulmonary toxicity from thalidomide in a patient with multiple myeloma","volume":"2","author":"Khalsa","year":"2007","journal-title":"Radiol Case Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/2042098612452291","article-title":"Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance","volume":"3","author":"Palumbo","year":"2012","journal-title":"Ther Adv Drug Safety."},{"key":"B53","first-page":"194","article-title":"Management of thalidomide toxicity","volume":"1","author":"Ghobrial","year":"2003","journal-title":"J Support Oncol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01248\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:46:16Z","timestamp":1590626776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01248\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2020.01248"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01248","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202005.0029.v1","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"article-number":"1248"}}